• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Safety and immunogenicity of an inactivated hepatitis A vaccine in preschool children.

作者信息

Balcarek K B, Bagley M R, Pass R F, Schiff E R, Krause D S

机构信息

Department of Pediatrics, University of Alabama at Birmingham.

出版信息

J Infect Dis. 1995 Mar;171 Suppl 1:S70-2. doi: 10.1093/infdis/171.supplement_1.s70.

DOI:10.1093/infdis/171.supplement_1.s70
PMID:7876652
Abstract

Young children in day care centers are an important source of hepatitis A virus (HAV) infection. The safety and immunogenicity of an inactivated HAV vaccine was evaluated in 57 children in day care centers. Nonimmune healthy children were given 0.5 mL of vaccine with subsequent doses: group A (28 children), second and third doses 1 and 2 months after the first; group B (29 children), second and third doses at 1 and 6 months. Antibody to HAV was measured before each dose and 8 months after the initial dose. All children developed antibody to HAV. Groups A and B had similar levels of antibody at 2 months; levels were lower in group B before the third dose and higher 8 months after the first dose. Local reactions after vaccination were reported in 17 children (29.8%). Minor systemic side effects that cleared spontaneously were observed in 27 children (47%).

摘要

相似文献

1
Safety and immunogenicity of an inactivated hepatitis A vaccine in preschool children.
J Infect Dis. 1995 Mar;171 Suppl 1:S70-2. doi: 10.1093/infdis/171.supplement_1.s70.
2
Immunogenicity, safety and tolerability of varying doses and regimens of inactivated hepatitis A virus vaccine in Navajo children.纳瓦霍儿童中不同剂量和方案的甲型肝炎病毒灭活疫苗的免疫原性、安全性和耐受性
Pediatr Infect Dis J. 1994 Jul;13(7):640-2. doi: 10.1097/00006454-199407000-00011.
3
Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals.灭活甲型肝炎疫苗:一项针对卫生专业人员的安全性和免疫原性研究。
J Infect Dis. 1995 Mar;171 Suppl 1:S50-2. doi: 10.1093/infdis/171.supplement_1.s50.
4
Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence.
J Med Virol. 1994 Dec;44(4):446-51. doi: 10.1002/jmv.1890440425.
5
Safety, immunogenicity and antibody persistence of an inactivated hepatitis A vaccine in 4 to 15 year old children.一种灭活甲肝疫苗在4至15岁儿童中的安全性、免疫原性及抗体持久性
Vaccine. 1999 Nov 12;18(7-8):656-64. doi: 10.1016/s0264-410x(99)00272-8.
6
Single dose-inactivated hepatitis A vaccination schedule for susceptible youngsters.易感青少年的单剂量甲型肝炎灭活疫苗接种计划。
Am J Gastroenterol. 1996 Jul;91(7):1360-2.
7
Immunization of US soldiers with a two-dose primary series of inactivated hepatitis A vaccine: early immune response, persistence of antibody, and response to a third dose at 1 year.用两剂次的甲型肝炎灭活疫苗基础免疫程序对美国士兵进行免疫接种:早期免疫反应、抗体持久性以及1年后对第三剂的反应
J Infect Dis. 1995 Mar;171 Suppl 1:S61-9. doi: 10.1093/infdis/171.supplement_1.s61.
8
Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine.
J Med Virol. 1994 Dec;44(4):452-6. doi: 10.1002/jmv.1890440426.
9
Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine.一种新型甲型肝炎灭活疫苗制剂的安全性和免疫原性
Vaccine. 1999 Apr 9;17(15-16):1919-25. doi: 10.1016/s0264-410x(98)00461-7.
10
Single dose inactivated hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicity.单剂量灭活甲型肝炎疫苗:安全性和免疫原性的理论依据及临床评估
J Med Virol. 1994 Dec;44(4):435-41. doi: 10.1002/jmv.1890440422.

引用本文的文献

1
Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020.美国甲型肝炎病毒感染预防:免疫实践咨询委员会建议,2020 年。
MMWR Recomm Rep. 2020 Jul 3;69(5):1-38. doi: 10.15585/mmwr.rr6905a1.
2
Hepatitis A Virus Prevention and Vaccination Within and Outside the Veterans Health Administration in Light of Recent Outbreaks.鉴于近期疫情,退伍军人健康管理局内部及外部的甲型肝炎病毒预防与疫苗接种
Fed Pract. 2018 Mar;35(Suppl 2):S32-S37.
3
Analysis of 5' nontranslated region of hepatitis A viral RNA genotype I from South Korea: comparison with disease severities.
韩国甲型肝炎病毒 RNA 基因型 I 5'非翻译区分析:与疾病严重程度的比较。
PLoS One. 2010 Dec 28;5(12):e15139. doi: 10.1371/journal.pone.0015139.
4
Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: results from a vaccine safety datalink study.大龄儿童、青少年及成人对多剂量疫苗接种计划的依从性:一项疫苗安全数据链研究的结果
Am J Public Health. 2009 Oct;99 Suppl 2(Suppl 2):S389-97. doi: 10.2105/AJPH.2008.151332.
5
A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines.对已获许可的病毒疫苗、其中一些安全性问题以及研究性病毒疫苗开发进展的综述。
J Infect. 2004 Oct;49(3):179-209. doi: 10.1016/j.jinf.2004.05.018.
6
Supplementary statement on hepatitis A prevention. Laboratory Centre for Disease Control.甲型肝炎预防补充声明。疾病控制实验室中心。
CMAJ. 1996 Aug 1;155(3):302-5.